Each plan for use of psychotropic medications must identify the potential harmful effect of the medications in nontechnical terms that all interdisciplinary team members can understand. Dosages, prescribed by the attending physician, physician's assistant, or certified nurse practitioner, may not interfere with the person's daily living activities. Usage must be approved by the interdisciplinary team as an integral part of the ISP. The pharmacist, with input from the interdisciplinary team, shall monitor and document the use of psychotropic medication at least quarterly for desired responses and adverse effects.

Source: 26 SDR 96, effective January 24, 2000; 27 SDR 63, effective December 31, 2000; 37 SDR 69, effective October 18, 2010.

General Authority: SDCL 27B-2-26(3).

Law Implemented: 42 C.F.R. § 483.450 (October 1, 2002).